Béchade Clémence, Lobbedez Thierry, Ivarsen Per, Povlsen Johan V
Néphrologie, CHU Clemenceau, Caen, France.
Néphrologie, CHU Clemenceau, Caen, France
Perit Dial Int. 2015 Nov;35(6):663-6. doi: 10.3747/pdi.2014.00344.
Older people are the largest and fastest growing group of patients with end-stage renal disease (ESRD), and, due to advanced age and a heavy burden of comorbidities, they are usually not candidates for renal transplantation or home-based dialysis treatment. Some of the barriers for home treatment are non-modifiable, but the majority of physical disabilities and psychosocial problems can be overcome provided that assistance is offered to the patients at home.In the present review, we describe the programs for assisted peritoneal dialysis (PD) in France and Denmark, respectively. In both nations, assisted PD is totally publicly funded, and the cost of assisted PD is comparable to the cost of in-center HD. Assisted continuous ambulatory PD (aCAPD) is the preferred modality in France whereas assisted automated PD (aAPD) is the preferred modality in Denmark. Assistants are professional nurses or healthcare technicians briefly educated by expert PD nurses from the dialysis unit.The establishment of a program for assisted PD may increase the number of patients actually treated with PD and may reduce the risk of PD technique failure and prolong PD duration. Compared with autonomous PD patients, patients on assisted PD may have shorter patient survival and peritonitis-free survival indicating that, besides advanced age and the burden of comorbidities, dependency on help may be an independent risk factor for poorer outcome.Assisted PD is an evolving dialysis modality, and may in the future prove to be a feasible complementary alternative to in-center hemodialysis (HD) for the growing group of dependent older patients with ESRD.
老年人是终末期肾病(ESRD)患者中规模最大且增长最快的群体,由于年龄较大且合并症负担沉重,他们通常不适合进行肾移植或居家透析治疗。居家治疗存在一些不可改变的障碍,但只要为患者提供居家协助,大多数身体残疾和心理社会问题是可以克服的。在本综述中,我们分别描述了法国和丹麦的辅助腹膜透析(PD)项目。在这两个国家,辅助PD完全由公共资金资助,且辅助PD的费用与中心血液透析(HD)的费用相当。辅助持续性非卧床腹膜透析(aCAPD)是法国首选的治疗方式,而辅助自动化腹膜透析(aAPD)是丹麦首选的治疗方式。助手是由透析单位的专业PD护士进行简短培训的专业护士或医疗技术人员。建立辅助PD项目可能会增加实际接受PD治疗的患者数量,并可能降低PD技术失败的风险,延长PD治疗时间。与自主进行PD的患者相比,接受辅助PD的患者可能有较短的患者生存期和无腹膜炎生存期,这表明除了年龄较大和合并症负担外,对他人帮助的依赖可能是导致预后较差的一个独立危险因素。辅助PD是一种不断发展的透析方式,未来可能会证明,对于日益增多的依赖他人的老年ESRD患者群体来说,它是中心血液透析(HD)一种可行的补充替代方案。